Literature DB >> 24210232

[Clinical practice guidelines: Presumed benign ovarian tumors--aims, methods, and organization].

J-L Brun1, X Fritel, J Levêque.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24210232     DOI： 10.1016/j.jgyn.2013.09.025

Source DB:  PubMed          Journal:  J Gynecol Obstet Biol Reprod (Paris)        ISSN： 0150-9918


× No keyword cloud information.
  2 in total

1.  Efficacy of HE4, CA125, Risk of Malignancy Index and Risk of Ovarian Malignancy Index to Detect Ovarian Cancer in Women with Presumed Benign Ovarian Tumours: A Prospective, Multicentre Trial.

Authors:  Vincent Dochez; Mélanie Randet; Céline Renaudeau; Jérôme Dimet; Aurélie Le Thuaut; Norbert Winer; Thibault Thubert; Edouard Vaucel; Hélène Caillon; Guillaume Ducarme
Journal:  J Clin Med       Date:  2019-10-25       Impact factor: 4.241

2.  Multiple biomarkers are more accurate than a combination of carbohydrate antigen 125 and human epididymis protein 4 for ovarian cancer screening.

Authors:  Kyung Nam Kang; Eun Young Koh; Ji Young Jang; Chul Woo Kim
Journal:  Obstet Gynecol Sci       Date:  2022-04-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.